Viewing Study NCT05972993


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-05-17 @ 11:43 AM
Study NCT ID: NCT05972993
Status: COMPLETED
Last Update Posted: 2025-05-28
First Post: 2023-08-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None SARS-CoV-2 View
None Master Protocol View
None Omicron View
None mRNA View